Pfizer

This Is the Easiest Way the U.S. Can Stop Corporate Tax Dodgers

Collect a corporate exit tax. Last week, the New York-based drugmaker Pfizer scuttled its proposed $150 billion merger with Irish-based competitor Allergan after the Obama administration rolled out new rules to curb the tax savings Pfizer hoped to glean from the deal. The episode again highlighted

April 12, 2016Steven M. Rosenthal

Individual Taxes: TaxVox

Tax Chauvinism: Who Cares Where a Firm is Incorporated?

Following the recent offer by U.S drugmaker Pfizer to acquire British pharmaceutical firm AstraZeneca, congressional Democrats are proposing new limits on the ability of U.S.-based firms to establish foreign residence as a way to cut their U.S. corporate tax bill. Even before this latest flap, the

May 20, 2014Howard Gleckman

Individual Taxes: TaxVox

Are Multinationals Getting Tired of Waiting for Corporate Tax Reform?

Is it possible that U.S.-based multinationals are getting tired of waiting for Congress to enact corporate tax reform? Seeking cash for domestic acquisitions, some of the nation’s best-known firms are starting to bring back their foreign earnings. Some are finding ways to avoid paying tax at all on

May 15, 2014Howard Gleckman